346
Reinstein et al.
13. Modestin J. Suizid in der psychiatrischen Klinik. Stuttgart:
Enke, 1987
Acknowledgements
14. Meltzer HY, Okayli G. Reduction of suicidality during cloz-
apine treatment of neuroleptic-resistant schizophrenia: im-
pact on risk-benefit assessment. Am J Psychiatry 1995; 152:
183-90
Funding support for this study was provided by Novartis
Pharmaceuticals.
15. Ehrlinger R. Evaluation of suicide prevention after attempted
suicide. Acta Psychiatr Scand Suppl 1975; 260: 64-124
16. Kreitman N, editor. Parasuicide. New York: John Wiley & Sons,
1977
References
1. Kane JM, Honigfeld G, Singer J, et al. Clozapine for treatment-
resistant schizophrenia. Arch Gen Psychiatry 1988; 45: 789-
96
17. Westermeyer JF, Harrow M, Marengo JT. Risk for suicide in
schizophrenia and other psychotic and non-psychotic dis-
2. Meltzer H, Burnett S, Bastani B, et al. Effects of six months of
clozapine treatment on the quality of life of chronic schizo-
phrenic patients. Hosp Community Psychiatry 1990; 41: 892-7
3. Pickar D, Owen RR, Litman RE, et al. Clinical and biological
response to clozapine in patients with schizophrenia: cross-
over comparison with fluphenazine. Arch Gen Psychiatry
1992; 49: 345-53
4. Breier A, Buchanan RW, Irish D, et al. Clozapine treatment of
outpatients with schizophrenia: outcome and long-term
response patterns. Hosp Community Psychiatry 1993; 22:
1145-9
5. Breier A, Buchanan RW, Kirkpatrick B, et al. Effects of cloza-
pine on postiive and negative symptoms in outpatients with
schizophrenia. Am J Psychiatry 1994; 151: 20-6
6. Lieberman JA, Safferman AZ, Pollack S, et al. Clinical effects
of clozapine in chronic schizophrenia: response to treatment
and preditctors of outcome. Am J Psychiatry 1994; 151: 1744-
52
7. Rosenheck R, Cramer J, Xu W, et al. Department of Veterans
Affairs Cooperative Study Group on Clozapine in Refractory
Schizophrenia. A comparison of clozapine and haloperidol in
hospitalised patients with refractory schizophrenia. N Engl J
Med 1997; 337: 809-15
orders. J Nerv Ment Dis 1991; 179: 259-66 (as cited in Reid[4]
)
18. Caldwell CB, Gottesman II. Schizophrenics kill themselves too:
A review of risk factors for suicide. Schizophr Bull 1990; 16:
571-89 (as cited in Reid[4]
)
19. Sernyak MJ, Desi R, Stolar M, et al. Impact of clozapine on
completed suicide. Am J Psychiatry 2001; 158: 931-7
20. Ereschefsky L, Watanabe MD, Tran-Johnson TK. Clozapine: an
typical antipsychotic agent. Clin Pharm 1989-8: 691-709
21. Lieberman JA, Alvir JMJ. A report of clozapine-induced agran-
ulocytosis in the United States. Incidence and risk factors.
Drug Saf 1992; 7: 1-2
22. Reinstein MJ, Sirotouskaya LA, Mohan SC, et al. Incidence and
treatment of side effects with clozapine treatment [poster].
Presented at the Annual Meeting of the American Psychiatric
Association, Chicago, 8 May 2000
23. Marder SR, Van Putten T. Who should receive clozapine? Arch
Gen Psychiatry 1988; 45: 865-7
24. Earle KA, Forquer SL, Volo AM, et al. Characteristics of out-
patient suicides. Hosp Community Psychiatry 1994; 45:
123-6
25. Meltzer HY. Suicide and schizophrenia: Clozapine and the
InterSePT study. J Clin Psychiatry 1999; 60 Suppl. 2: 47-50
26. Taiminen TJ, Kujari H. Antipsychotic medication and suicide
risk among schizophrenic and paranoid inpatients. Acta Psy-
8. Gelder M. Gath D, Mayou R, et al. (editors) Schizophrenia and
schizophrenia-like disorders. In: Oxford Textbook of Psych-
iatry. 3rd ed. New York: Oxford University Press, 1996: 246-
293
9. Jablensky A. Epidemiology of schizophrenia: a European per-
spective. Schizophr Bull 1986; 12: 52-73
10. Hafner H, Riecher A, Maurer K, et al. How does gender in-
fluence age at first hospitalization of schizophrenia. Psychol
Med 1989; 19: 903-18
chiatr Scand 1994; 90: 247-51 (as cited in Meltzer[25]
)
27. Walker AM, Lanza LL, Arellano F, et al. Mortality in current
and former users of clozapine. Epidemiology 1997; 8: 671-7
(as cited in Meltzer[25]
)
28. Meltzer HY. Suicide in schizophrenia: Risk factors and clozap-
ine treatment. J Clin Psychiatry 1988; 59 Suppl. 3: 15-20
11. Reid WH, Mason M, Hogan T. Suicide prevention effects asso-
ciated with clozapine therapy in schizophrenia and schizo-
affective disorder. Psychiatr Serv 1998; 49 (8): 1029-33
12. Schuttler R, Huber G, Gross G. Suizid and Suizidversuch im
Verlauf schizophrener Erkrankungen. Psychiatr Clin (Basel)
1976; 9: 97-105
Correspondence and offprints: Dr John G. Sonnenberg,
Uptown Research Institute, LLC, 4755 N. Kenmore Ave-
nue, Chicago, IL 60640, USA.
© Adis International Limited. All rights reserved.
Clin Drug Invest 2002; 22 (5)